Daniel Clauw, MD, is professor of medicine, anesthesia, and psychiatry at the University of Michigan and director of the Chronic Pain and Fatigue Research Center. In this era of increasing opioid abuse and overdoses, and harsh criticism for physicians' use of opioids in the setting of chronic pain, he shared his (not at all subtle) opinion in a "Doc to Doc" conversation with me.

Despite treating patients with a range of chronic pain issues, from fibromyalgia to interstitial cystitis to low back pain, Clauw says, "I haven't prescribed an opioid for chronic pain in at least a decade." With that phrase, he has thrown down the gauntlet to other docs who feel that opioids are an acceptable, if lamentable, option for chronic pain treatment. Indeed, Clauw feels that doctors jump too quickly to opioids when patients might be better managed with tricyclics, gabapentinoids, or even complementary and alternative therapies.

Are docs responsible for the opioid epidemic? Clauw states that we have certainly played a role. He calls out surgeons and dentists who prescribe 30 days (or more) of opioids routinely postoperatively. Surgeons "give these large prescriptions of opioids because they don't want to be called back for pain ... I get that that makes your job easier."

Whether you find his viewpoint insightful or woefully unrealistic, his advice may very well stick with you. Watch the video to hear all of his observations.

F. Perry Wilson, MD, MSCE, is an assistant professor of medicine at the Yale School of Medicine. He earned his BA from Harvard University, graduating with honors with a degree in biochemistry. He then attended Columbia College of Physicians and Surgeons in New York City. From there he moved to Philadelphia to complete his internal medicine residency and nephrology fellowship at the Hospital of the University of Pennsylvania. During his post graduate years, he also obtained a Master of Science in Clinical Epidemiology from the University of Pennsylvania. He is an accomplished author of many scientific articles and holds several NIH grants. He is a MedPage Today reviewer, and in addition to his video analyses, he authors a blog, The Methods Man. You can follow @methodsmanmd on Twitter.